Anixa Biosciences Inc (ANIX)
2.99
-0.10
(-3.24%)
USD |
NASDAQ |
May 02, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Market Cap: 95.38M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 95.38M |
| May 01, 2024 | 98.57M |
| April 30, 2024 | 94.74M |
| April 29, 2024 | 96.34M |
| April 26, 2024 | 103.04M |
| April 25, 2024 | 95.06M |
| April 24, 2024 | 101.44M |
| April 23, 2024 | 97.93M |
| April 22, 2024 | 96.02M |
| April 19, 2024 | 99.53M |
| April 18, 2024 | 98.89M |
| April 17, 2024 | 97.29M |
| April 16, 2024 | 101.12M |
| April 15, 2024 | 100.80M |
| April 12, 2024 | 101.12M |
| April 11, 2024 | 102.72M |
| April 10, 2024 | 102.08M |
| April 09, 2024 | 103.67M |
| April 08, 2024 | 101.12M |
| April 05, 2024 | 102.08M |
| April 04, 2024 | 100.17M |
| April 03, 2024 | 104.63M |
| April 02, 2024 | 102.08M |
| April 01, 2024 | 106.86M |
| March 28, 2024 | 99.53M |
| Date | Value |
|---|---|
| March 27, 2024 | 103.04M |
| March 26, 2024 | 99.85M |
| March 25, 2024 | 103.04M |
| March 22, 2024 | 110.37M |
| March 21, 2024 | 117.71M |
| March 20, 2024 | 118.99M |
| March 19, 2024 | 114.84M |
| March 18, 2024 | 111.97M |
| March 15, 2024 | 117.71M |
| March 14, 2024 | 98.25M |
| March 13, 2024 | 101.44M |
| March 12, 2024 | 98.25M |
| March 11, 2024 | 102.57M |
| March 08, 2024 | 103.20M |
| March 07, 2024 | 109.55M |
| March 06, 2024 | 111.14M |
| March 05, 2024 | 113.05M |
| March 04, 2024 | 118.13M |
| March 01, 2024 | 111.46M |
| February 29, 2024 | 111.14M |
| February 28, 2024 | 111.46M |
| February 27, 2024 | 112.73M |
| February 26, 2024 | 109.24M |
| February 23, 2024 | 114.00M |
| February 22, 2024 | 113.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.36M
Minimum
Mar 27 2020
190.68M
Maximum
Mar 17 2021
102.04M
Average
100.92M
Median
Jan 13 2021
Market Cap Benchmarks
| CEL-SCI Corp | 79.89M |
| AIM ImmunoTech Inc | 20.17M |
| IGC Pharma Inc | 33.14M |
| NovaBay Pharmaceuticals Inc | 2.709M |
| Protalix BioTherapeutics Inc | 84.74M |
Market Cap Related Metrics
| Price to Book Value | 3.876 |
| Price | 2.99 |
| Earnings Yield | -11.37% |